The plan of enrichment designs for dealing with high placebo response-Reference-Cited by-同舟云学术

The plan of enrichment designs for dealing with high placebo response

Published:2017-11-01 Issue:1 Volume:17 Page:25-37
ISSN:1539-1604
Container-title:Pharmaceutical Statistics
language:en
Short-container-title:Pharmaceutical Statistics

Author:

Zhang Xiangmin¹,Chen Yeh-Fong²^ORCID,Tamura Roy³

Affiliation:

1. The University of Iowa; Iowa City IA USA

2. Division of Biometric III, Office of Biostatistics, Office of Translational Sciences, Center of Drug Evaluation and Research (CDER); US Food and Drug Administration; Silver Spring MD USA

3. Health Informatics Institute; University of South Florida; Tampa FL USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology,Statistics and Probability

Reference27 articles.

1. Placebo response in studies of major depression: variable, substantial, and growing;Walsh;JAMA,2002

2. The problem of the placebo response in clinical trials for psychiatric disorders: culprits, possible remedies, and a novel study design approach;Fava;Psychother Psychosom,2003

3. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications;Khin;J Clin Psychiatry,2011

4. Exploratory analyses of efficacy data from schizophrenia trials in support of new drug applications submitted to the US Food and Drug Administration;Khin;J Clin Psychiatry,2012

5. Placebo response in clinical trials with schizophrenia patients;Kinon;Curr Opin Psychiatry,2011

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sequential parallel comparison design with two coprimary endpoints;Pharmaceutical Statistics;2019-12-12

2. Notes on power comparison between the sequential parallel comparison and other commonly-used designs;Communications in Statistics - Simulation and Computation;2019-10-26

3. Sequential parallel comparison design for “gold standard” noninferiority trials with a prespecified margin;Biometrical Journal;2019-08-28